Skip to main content
Have a personal or library account? Click to login
Isoflavonoids — an overview of their biological activities and potential health benefits Cover

Isoflavonoids — an overview of their biological activities and potential health benefits

By:   
Open Access
|Jan 2010

References

  1. Akhter M, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S. (2008). Dietary soy isoflavone intake and risk of colorectal cancer in the Japan Public Health Cancer-based prospective study.(8): 2128-2135.
  2. Atkinson C, Warren RM, Sala E, Dowsett M, Dunning AM, Healey CS, Runswick S, Day NE, Bingham SA. (2004). Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial.(3): 170-179.
  3. Barnes S. (2004). Soy isoflavones - phytoestrogens and what else?: 1225S-1228S.
  4. Bezek S, Ujhazy E, Mach M, Navarova J, Dubovicky M. (2008). Developmental origin of chronic diseases: toxicological implication.(1): 29-31.
  5. Birt DF, Hendrich S, Wang W. (2001). Dietary agents in cancer prevention: flavonoids and isoflavonoids.(2-3): 157-177.
  6. Boccia S, La Torre G, Gianfagna F, Mannocci A, Ricciardi G. (2005). N-Acetyltransferase 2 status and gastric cancer risk: a preliminary meta-analysis.: 53-57.
  7. Cesarone MR, Grossi MG, Di Renzo, A, Errich S, Schönlau F, Wilmer JL, Lange M, Blimenfeld J. (2009). Accelerated antioxidant bioavailability of OPC-3® bioflavonoids administered as isotonic solution.(6): 775-777.
  8. Chen Y, Gammon MD, Teitelbaum SL, Britton JA, Terry MB, Shantakumar S, Eng SM, Wang Q, Gurvich I, Neugut AI, Santella RM, Ahsan H. (2008). Estrogen-biosynthesis geneand its interactions with reproductive hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project.(4): 766-771.
  9. Cherdshewasart W, Sutjit W. (2008). Correlation of antioxidant activity and major isoflavonoid contents of the phytoestrogen-richtubers.(1-2): 38-43.
  10. Chodon D, Ramamurty N, Sakthisekan D. (2007). Inhibition of cell proliferation and induction of apoptosis by genistein in hepatocellular carcinoma.(5): 887-891.
  11. Chrzan BG, Bradford PG. (2007). Phytoestrogens activate estrogen receptor β1 and estrogenic responses in human breast and bone cancer cell lines.: 171-177.
  12. Dixon RA, Summer LW. (2003.) Legume natural products: Understanding and manipulating complex pathways for human and animal health.: 878-885.
  13. Duffy C, Perez K, Partridge A. (2007). Implications of phytoestrogen intake for breast cancer.: 260-277.
  14. Eliassen AH, Missmer SA, Tworoger SS, Hankinson SE. (2008). Circulating 2-hydroxy and 16a-hydroxy estrone levels and risk of breast cancer among post-menopausal women.(8): 2029-2035.
  15. Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Gaudet MM, Abrahamson PE, Bell P, Schroeder JC, Teiltelbaum SL, Neugut AI, Gammon MD. (2007). Dietary flavonoid intake and breast cancer survival among women on Long Island.: (11): 2285-2292.
  16. Goodman MT, Shvetsov YB, Wilkens LR, Franke AA, Marchand LL, Kazaku KK, Nomura AMY, Henderson BE, Kolonel LN. (2009). Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study.: 887.
  17. Hirschberg AL, Edlund M, Svane G, Azavedo E, Skoog L, von Schoultz B. (2007). An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women.(1): 89-96.
  18. Hedlund TE, van Bokhaven A, Johannes WU, Nordeen SK, Ogden LG. (2005) Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant epithelial cells(5): 557-566.
  19. Ito C, Murata T, Itoigawa M, Nakao K, Kumagai M, Kaneda N, Furukawa H. (2006). Induction of apoptosis by isoflavonoids from leaves ofin human leukemia HL-60 cells.(5): 424-429.
  20. Iwasaki M, Inoue M, Otani T, Sasazuki S, Kurashi N, Miura T, Yamoto S, Tsugane S. (2008). Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from Japan Public Health Center-base prospective study group.(10): 1677-1683.
  21. Ju IH, Allred KF, Allred CD, Helferich WG. (2006). Genistein stimulates growth of human breast cancer cells in a novel postmenopausal animal model, with low plasma estradiol concentrations.: 1292-1299.
  22. Kousidou OC, Tzanakakis GN, Karamanos NK. (2006). Effects of natural isoflavonoid genistein on growth, signaling pathway and gene expression of matrix macromolecules by breast cancer cells.(3): 331-337.
  23. Kralova J, Pekarova M, Drabikova K, Jancinova V, Nosal R, Ciz M, Lojek A. (2008). The effects of dithiaden on nitric oxide production by RAW 264.7 cells.(3-4): 214-217.
  24. Lampe JW. (2009). Is equol the key to the efficacy of soy foods?: 1664S-1667S.
  25. Lockwood B. (2008). The beneficial effects of soy isoflavones in osteoporosis of the elderly.(5):38-41.
  26. Liu B, Edgerton S, Yang X. (2005). Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention.: 879-886.
  27. Maskarinec G, Williams AE, Carlin L. (2003). Mammographic densities in a oneyear isoflavone intervention.(2):165-169.
  28. Maskarinec G, Hebshi S, Custer L, Franke AA. (2008a). The relation of soy intake and isoflavone levels in nipple aspirate fluid.(1): 67-70.
  29. Maskarinec G, Watts K, Kagihara J, Hebshi SM, Franke AA. (2008b) Urinary isoflavonoid is similar after consuming soya milk and miso soup in Japanese-American women.: 424-429.
  30. Maskarinec G, Verheus M, Steinberg FM, Amato P, Cramer M, Lewis RD, Murray MJ, Yong RL, Wong WW. (2009). Various doses of isoflavones do not modify mammographic density in postmenopausal women.(5): 981-986.
  31. Messina M, Wood CE. (2008). Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.(1): 17-28.
  32. Messina M, McCaskill-Stevens W, Lampe JW. (2006). Addressing the soy and breast cancer relatioship: review, commentary, and workshop proceedings.(18): 1275-1284.
  33. Miadokova E, Masterova I, Vlckova V, Duhova V, Toth J. (2002). Antimutagenic potential of homoisoflavonoids from: 381-386.
  34. Murata IC, Itoigawa M, Nakao K, Kumagai M, Kaneda N, Furukawa H. (2006). Induction of apoptosis by isoflavonoids from the leaves ofin human leukemia HL-60 cells.(5): 424-429.
  35. Myasoedova VA, Sobenin IA. (2008). Background, rationale and design of clinical study of the effect of isoflavonoid-rich botanicals on natural history of atherosclerosis in women.Suppl.(1): 171.
  36. Nagata C, Nakamura K, Fujii K, Kawachi T, Takatsuka N, Oba S, Shimizu H. (2008). Soy isoflavone intake is not associated with the development od cedar pollinosis in adults.: 1372-1376
  37. Ørgaard A, Jensen L. (2008). The effects of soy isoflavones on obesity: 1066-1080.
  38. Perry DL, Spedick JM, McCoy TP, Adams MR, Franke AA, Cline JM. (2007). Dietary soy protein containing isoflavonoids does not adversely affect the reproductive tract of male cynomolgus macaques: 1390-1394.
  39. Piller R, Chang-Claude J, Linseisen J. (2006). Plasma enterolactone and genistein and the risk of premenopausal breast cancer.(3): 225-232.
  40. Raju J, Bielecki A, Caldwell D, Lok E, Taylor M, Kapal K, Curran I, Cooke GM, Bird RP, Mehta R. (2009). Soy isoflavones modulate azoxymethane-induced rat colon carcinogenesis exposed pre- and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells increasing the expression of estrogen receptor beta.(3): 474-4781.
  41. Ralston L, Subramanian S, Matsuto M, Yu O. (2005). Partial reconstruction of flavoid and soflavoid biosynthesis in yeast using soybean Type I and Type II chalcone isomerases.(4): 1375-1388.
  42. Reiter RJ, Paredes SD, Kormaz A, Jou M-J, Tan D-X. (2008). Melatonin combats molecular terrorism at the mitochondrial level(2): 137-149.
  43. Rice S, Mason HD, Whitehead SA. (2006). Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells.(4-5): 216-225.
  44. Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR, Beerman KA. (2006). Soy isoflavones modulate immune function in healthy postmenopausal women.: 118-1125.
  45. Sabudak T, Guler N. (2009).L.- A review on its phytochemical and pharmacological profile.: 439-446.
  46. Shen P, Liu MH, Ng TY, Chan YH, Long EL. (2006) Differential effects of isoflavones, fromand, on the activation of PPARalpha, PPAR gamma, and adipocyte differentiation: 899-905.
  47. Scarpato R, Paganucci L, Bertoli A, Fiore L, Pistelli L, Federico G. (2008). Licoflavone C attenuates the genotoxicity of cancer drugs in human peripheral lymphocytes.(12): 1650-1654.
  48. Shen P, Liu MH, Ng TY, Chan YH, Yong EL. (2006). Differential effects of isoflavones, fromand, on the activation of PPARalpha, PPAR gamma, and adipocyte differentiation: 899-905.
  49. Stienstra R, Duval C, Ller M, Kersten S. (2007). PPARs, obesity, and inflammation.2007: 95974.
  50. Su Y, Simmen RCM. (2009). Soy isoflavone genistein upregulates epithelian adhesion molecule E-cadherin expression and β-catenin signaling in mammary epithelial cells.(2): 331-339.
  51. Talbott KE, Gammon MD, Kibriva MG, Chen Y, Teilbaum SL, Long CM, Gurvich I, Santella RM, Ahsan H. (2008). A(aromatase) polymorphism is associated with increased premenopausal breast cancer risk.(3): 481-487.
  52. Tamini RM, Hankinson SE, Coldiz GA, Byrne C. (2005). Endogenous sex hormone levels and mammographic density among postmenopausal women.: 2641-2647.
  53. Thorp AA, Howe PR, Mori TA, Coates AM, Buckley JD, Hodgson J, Mansour J, Meyer BJ. (2008.) Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers.(2): 298-304.
  54. Verheus M, van Gils CH, Kreijkamp-Kaspers S, Kok L, Peeters PH, Grobbee DE, van der Schouw YT. (2008). Soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women.(10): 2632-2638.
  55. Wang Y, Gho WM, Chan FL, Chen S, Leung LK. (2008). The red clover () isoflavone biochanin A inhibits aromatase activity and expression.: 303-310.
  56. Wood CE, Appt S, Clarkson TB, Franke AA, Lees C, Doerge DR, Cline JM. (2006). Effects of high-dose soy isoflavones and equol on reproductive tissues in female cynomolgus monkeys.(3): 477-486.
  57. Wood CE, Register TC, Cline JM. (2007). Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys.(4): 801-808.
  58. Widyarini S, Domanski D, Painter N, Reeve VE. (2006). Estrogen receptor signaling protects against immune suppression by UV radiation exposure.(34): 12837-12842.
DOI: https://doi.org/10.2478/v10102-009-0021-3 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 211 - 218
Published on: Jan 6, 2010
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services

© 2010 Eva Miadoková, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.